Beth Zelnick - Sep 9, 2025 Form 4 Insider Report for CorMedix Inc. (CRMD)

Signature
/s/ Beth Zelnick Kaufman
Stock symbol
CRMD
Transactions as of
Sep 9, 2025
Transactions value $
-$505,264
Form type
4
Date filed
9/11/2025, 09:45 PM
Previous filing
Sep 8, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Zelnick Kaufman Beth Chief Legal Officer C/O CORMEDIX INC., 300 CONNELL DRIVE, SUITE 4200, BERKELEY HEIGHTS /s/ Beth Zelnick Kaufman 2025-09-11 0002004480

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRMD Common Stock Options Exercise $165K +50K +27.71% $3.30 230K Sep 9, 2025 Direct
transaction CRMD Common Stock Sale -$665K -49.6K -21.53% $13.41 181K Sep 9, 2025 Direct F1
transaction CRMD Common Stock Sale -$5.13K -400 -0.22% $12.82 180K Sep 9, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRMD Stock Option (Right to Buy Common Stock) Options Exercise $0 -50K -25% $0.00 150K Sep 9, 2025 Common Stock 50K $3.30 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $12.83 to $13.82. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F2 These options were granted on 12/12/2023. These options vest over four years in four equal installments on the first four anniversaries of the grant date, subject to continued employment through the applicable vesting date.